Decrease in IL-4 Expression after Immunotherapy with Local House Dust Mite Allergen in Atopic Dermatitis BALB/c Mice

The efficacy of immunotherapy in atopic dermatitis (AD) patients has been debated in years. Study of immunotherapy in AD mouse model can help finding objective information in the mechanism of immunotherapy, especially interleukin (IL)-4 that widely known has important role in AD pathogenesis. Thirt...

Full description

Bibliographic Details
Main Authors: Sylvia Anggraeni, Siti Farida, Anang Endaryanto, Cita Rosita Sigit Prakoeswa
Format: Article
Language:English
Published: Assiut University 2023-04-01
Series:Journal of Advanced Veterinary Research
Subjects:
Online Access:https://advetresearch.com/index.php/AVR/article/view/1175
_version_ 1797657060598349824
author Sylvia Anggraeni
Siti Farida
Anang Endaryanto
Cita Rosita Sigit Prakoeswa
author_facet Sylvia Anggraeni
Siti Farida
Anang Endaryanto
Cita Rosita Sigit Prakoeswa
author_sort Sylvia Anggraeni
collection DOAJ
description The efficacy of immunotherapy in atopic dermatitis (AD) patients has been debated in years. Study of immunotherapy in AD mouse model can help finding objective information in the mechanism of immunotherapy, especially interleukin (IL)-4 that widely known has important role in AD pathogenesis. Thirty-three male BALB/c mice aged 6-8 weeks were randomly assigned to 3 different groups: immunotherapy, AD model, and control group. The mice in immunotherapy and AD model group were sensitized with house dust mites (HDM) Dermatophagoides pteronyssinus (Der-p) allergen extract, patched for the first 7 days and nebulized continuously from day 1-93. Subcutaneous Der-p immunotherapy injection was given every 3 days in increasing doses. The skin samples were taken on day 93 and was assessed for IL-4 with immunohistochemistry method. The data were analyzed with comparative analysis. The mice in immunotherapy group had lower IL-4 expression compared to AD model group which received placebo injections, and slightly higher than the control group. The mean IL-4 expression comparison between groups of mice was not significant (p = 0.098). This study found a decrease of IL-4 after immunotherapy with local HDM allergen in AD BALB/c mice compared to placebo group.
first_indexed 2024-03-11T17:38:55Z
format Article
id doaj.art-8e90e098f8394833baca869a2ee13465
institution Directory Open Access Journal
issn 2090-6269
2090-6277
language English
last_indexed 2024-03-11T17:38:55Z
publishDate 2023-04-01
publisher Assiut University
record_format Article
series Journal of Advanced Veterinary Research
spelling doaj.art-8e90e098f8394833baca869a2ee134652023-10-18T14:22:10ZengAssiut UniversityJournal of Advanced Veterinary Research2090-62692090-62772023-04-01132Decrease in IL-4 Expression after Immunotherapy with Local House Dust Mite Allergen in Atopic Dermatitis BALB/c MiceSylvia Anggraeni0Siti Farida1Anang Endaryanto2Cita Rosita Sigit Prakoeswa3Department of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital, Indonesia.Pharmacy Unit, Dr. Soetomo General Academic Hospital, Indonesia.Department of Pediatrics, Faculty of Medicine Universitas Airlangga/Dr. Soetomo General Academic Hospital, IndonesiaDepartment of Dermatology and Venereology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital, Surabaya The efficacy of immunotherapy in atopic dermatitis (AD) patients has been debated in years. Study of immunotherapy in AD mouse model can help finding objective information in the mechanism of immunotherapy, especially interleukin (IL)-4 that widely known has important role in AD pathogenesis. Thirty-three male BALB/c mice aged 6-8 weeks were randomly assigned to 3 different groups: immunotherapy, AD model, and control group. The mice in immunotherapy and AD model group were sensitized with house dust mites (HDM) Dermatophagoides pteronyssinus (Der-p) allergen extract, patched for the first 7 days and nebulized continuously from day 1-93. Subcutaneous Der-p immunotherapy injection was given every 3 days in increasing doses. The skin samples were taken on day 93 and was assessed for IL-4 with immunohistochemistry method. The data were analyzed with comparative analysis. The mice in immunotherapy group had lower IL-4 expression compared to AD model group which received placebo injections, and slightly higher than the control group. The mean IL-4 expression comparison between groups of mice was not significant (p = 0.098). This study found a decrease of IL-4 after immunotherapy with local HDM allergen in AD BALB/c mice compared to placebo group. https://advetresearch.com/index.php/AVR/article/view/1175atopic dermatitisBALB/c micehouse dust mitesIL-4tropical disease
spellingShingle Sylvia Anggraeni
Siti Farida
Anang Endaryanto
Cita Rosita Sigit Prakoeswa
Decrease in IL-4 Expression after Immunotherapy with Local House Dust Mite Allergen in Atopic Dermatitis BALB/c Mice
Journal of Advanced Veterinary Research
atopic dermatitis
BALB/c mice
house dust mites
IL-4
tropical disease
title Decrease in IL-4 Expression after Immunotherapy with Local House Dust Mite Allergen in Atopic Dermatitis BALB/c Mice
title_full Decrease in IL-4 Expression after Immunotherapy with Local House Dust Mite Allergen in Atopic Dermatitis BALB/c Mice
title_fullStr Decrease in IL-4 Expression after Immunotherapy with Local House Dust Mite Allergen in Atopic Dermatitis BALB/c Mice
title_full_unstemmed Decrease in IL-4 Expression after Immunotherapy with Local House Dust Mite Allergen in Atopic Dermatitis BALB/c Mice
title_short Decrease in IL-4 Expression after Immunotherapy with Local House Dust Mite Allergen in Atopic Dermatitis BALB/c Mice
title_sort decrease in il 4 expression after immunotherapy with local house dust mite allergen in atopic dermatitis balb c mice
topic atopic dermatitis
BALB/c mice
house dust mites
IL-4
tropical disease
url https://advetresearch.com/index.php/AVR/article/view/1175
work_keys_str_mv AT sylviaanggraeni decreaseinil4expressionafterimmunotherapywithlocalhousedustmiteallergeninatopicdermatitisbalbcmice
AT sitifarida decreaseinil4expressionafterimmunotherapywithlocalhousedustmiteallergeninatopicdermatitisbalbcmice
AT anangendaryanto decreaseinil4expressionafterimmunotherapywithlocalhousedustmiteallergeninatopicdermatitisbalbcmice
AT citarositasigitprakoeswa decreaseinil4expressionafterimmunotherapywithlocalhousedustmiteallergeninatopicdermatitisbalbcmice